Enquiry Now
Loading...
| A03797 | Pages: NA | Aug 2021 | 3495 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pneumococcal Polysaccharide Vaccine Market
Request Now !Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age. Pneumococcal polysaccharide vaccine is derived from a capsular polysaccharide. These vaccinations induce specific antibodies, which kills the bacteria by opsonization or phagocytosis.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23. However, high costs associated with the development of such vaccines and longer timelines required for pneumonia vaccine production hamper the growth of the global pneumococcal polysaccharide vaccine market. Growing awareness about pneumococcal vaccine and large numbers of mergers & acquisition strategies among key vendors are expected to propel the growth of the market in the near future.
The global pneumococcal polysaccharide vaccine market is segmented on the basis of dosage, end user, and region. On the basis of dosage, the market is segmented into single dose vial and pre-filled syringe. On the basis of end user, the market is segmented into children (2-10 age), adults (10-64 age), and geriatric (more than 65 age). Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in this market include Merck & Co., Inc., Pfizer Inc., Glaxosmithkline Plc., Sanofi Pasteur, China National Biotec Group, Astellas Pharma Inc, and Serum Institute of India Pvt. Ltd.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Porters Five Forces Analysis
3.3 Market Share Analysis, 2016
3.4 Market Dynamics
3.4.1 Drivers
3.4.2 Restraints
3.4.3 Opportunities
CHAPTER 4 GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET, BY DOSAGE
4.1 Overview
4.2 Market size and forecast
4.3 Single Dose Vial
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Pre-Filled Syringe
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
CHAPTER 5 GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET, BY END USER
5.1 Overview
5.2 Market size and forecast
5.3 Children(2-10 Age)
5.3.1 Market size and forecast
5.4 Adult (10-64 Age)
5.4.1 Market size and forecast
5.5 Geriatric (More Than 65 Age)
5.5.1 Market size and forecast
CHAPTER 6 GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.3.1 U.S. market size and forecast
6.2.3.2 Canada market size and forecast
6.2.3.3 Mexico market size and forecast
6.2.4 North America pneumococcal polysaccharide vaccine market by dosage
6.2.5 North America pneumococcal polysaccharide vaccine market by end user
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.3.1 Germany market size and forecast
6.3.3.2 France market size and forecast
6.3.3.3 UK market size and forecast
6.3.3.4 Italy market size and forecast
6.3.3.5 Spain market size and forecast
6.3.3.6 Rest of Europe market size and forecast
6.3.4 Europe pneumococcal polysaccharide vaccine market by dosage
6.3.5 Europe pneumococcal polysaccharide vaccine market by end user
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.3.1 Japan market size and forecast
6.4.3.2 China market size and forecast
6.4.3.3 India market size and forecast
6.4.3.4 South Korea market size and forecast
6.4.3.5 Rest of Asia-Pacific market size and forecast
6.4.4 Asia-Pacific pneumococcal polysaccharide vaccine market by dosage
6.4.5 Asia-Pacific pneumococcal polysaccharide vaccine market by end user
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.3.1 Brazil market size and forecast
6.5.3.2 Saudi Arabia market size and forecast
6.5.3.3 South Africa market size and forecast
6.5.3.4 Rest of LAMEA market size and forecast
6.5.4 LAMEA pneumococcal polysaccharide vaccine market by dosage
6.5.5 LAMEA pneumococcal polysaccharide vaccine market by end user
CHAPTER 7 COMPANY PROFILES
7.1 Merck & Co., Inc.
7.1.1 Overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Operating segment overview
7.1.5 Strategic moves and developments
7.2 Pfizer Inc.
7.2.1 Overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Operating segment overview
7.2.5 Strategic moves and developments
7.3 GlaxoSmithKline plc.
7.3.1 Overview
7.3.2 Company snapshot
7.3.3 Business performance
7.3.4 Operating segment overview
7.3.5 Strategic moves and developments
7.4 Sanofi Pasteur
7.4.1 Overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Operating segment overview
7.4.5 Strategic moves and developments
7.5 China National Biotec Group
7.5.1 Overview
7.5.2 Company snapshot
7.5.3 Business performance
7.5.4 Operating segment overview
7.5.5 Strategic moves and developments
7.6 Astellas Pharma Inc
7.6.1 Overview
7.6.2 Company snapshot
7.6.3 Business performance
7.6.4 Operating segment overview
7.6.5 Strategic moves and developments
7.7 Serum Institute of India Pvt. Ltd.
7.7.1 Overview
7.7.2 Company snapshot
7.7.3 Business performance
7.7.4 Operating segment overview
7.7.5 Strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
